Depixus in the news

We regularly participate in the world’s leading conferences on tools and technologies for biomolecular analysis and therapeutics. Look out for our presentations and come and say hello to learn more about MAGNA™ and its transformative potential for life sciences research and drug development.

Depixus selected for SLAS 2024 Innovation AveNEW Award

PARIS, FRANCE – Interactomics pioneer Depixus is proud to announce they have been selected for the prestigious Innovation AveNEW showcase at the Society for Laboratory Automation and Screening (SLAS) International Conference & Exhibition, to be held in Boston from 3rd-7th February 2024. Designed to highlight exciting companies providing game-changing technologies for the life sciences, the …

Read More

Depixus to showcase unique single molecule technology solving the hit-to-lead challenge in RNA-targeted drug discovery at upcoming Discovery on Target Conference

PARIS–(BUSINESS WIRE)–Dr Gordon Hamilton, President & CEO of Depixus SAS, will be showcasing the company’s pioneering approach to transform RNA…

Read More